Obesity and breast cancer risk: the oncogenic implications of metabolic dysregulation. Naaman S, Shen S, Zeytinoglu M, Iyengar NM, et al. J Clin Endocrinol Metab 2022 Apr 22. pii: 6572669. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Naaman S, Shen S, Zeytinoglu M, Iyengar NM, et al. Obesity and breast cancer risk: the oncogenic implications of metabolic dysregulation. J Clin Endocrinol Metab 2022 Apr 22. pii: 6572669. doi: 10.1210.
PMID: 35453151